Elevate your operation's quality, compliance, and efficiency with MediZap. Discover how our unique blend of technology, expertise, and service can transform your business today!
The future of compounding is here!
We are on the cusp of a new era in compounding, and MediZap is at the forefront. With advancements in gene sequencing, gene expression, and targeted therapeutics, we are ushering in a new drug development and delivery frontier.
MediZap is committed to providing the safest and most effective compounded sterile drug preparations. We proudly offer new advanced terminal sterilization by irradiation technology to an ever-expanding API product portfolio. Our subject matter expertise, technology, services, products, and brand reputation make us the ideal partner for your compounding needs.
With MediZap's vision of 503A Plus, we are bringing the compounding industry into the cGMP world. This will allow us to deliver the most effective custom compounded sterile drug preparations while guiding ISO parametric release capabilities to forgo USP 71 lot-based restrictions.
With MediZap's vision of 503B Advance, we are bringing cGMP compliance, allowing us to deliver the safest, most effective, sterile manufacturing operations. This will set you up for success in pre-validated FDA drug shortage portfolios to meet patient needs and hospital network demands.
We are excited to be a part of this revolution in compounding, and we invite you to join us. We can create a future where everyone can access safe and effective sterile medications.
